nach oben

Erschienen in:

01.06.2019 | News item

RXQ Compounding voluntarily recalls all sterile products

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

RXQ Compounding is voluntarily recalling all of its sterile products for both human and veterinary use due to a lack of sterility process assurance, says the US FDA. …

US Food and Drug Administration. RXQ Compounding, LLC Issues Voluntary Nationwide Recall of All Sterile Products within Expiry and Voluntarily Cessation of Production Due to the Lack of Sterility Process Assurance. Internet Document : 18 Jun 2019. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/rxq-compounding-llc-issues-voluntary-nationwide-recall-all-sterile-products-within-expiry-and

Titel: RXQ Compounding voluntarily recalls all sterile products
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63892-8

Springer Medizin

RXQ Compounding voluntarily recalls all sterile products

Excerpt

Weitere Artikel der Ausgabe 1/2019

Mifepristone

Valproic-acid

Amiodarone

Rivaroxaban

Hydrocortisone

Indometacin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Mifepristone

Valproic-acid

Amiodarone

Rivaroxaban

Hydrocortisone

Indometacin